These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 19615978)
1. Statins and angiogenesis: is it about connections? Khaidakov M; Wang W; Khan JA; Kang BY; Hermonat PL; Mehta JL Biochem Biophys Res Commun; 2009 Sep; 387(3):543-7. PubMed ID: 19615978 [TBL] [Abstract][Full Text] [Related]
2. Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. Massaro M; Zampolli A; Scoditti E; Carluccio MA; Storelli C; Distante A; De Caterina R Cardiovasc Res; 2010 May; 86(2):311-20. PubMed ID: 19946014 [TBL] [Abstract][Full Text] [Related]
3. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651 [TBL] [Abstract][Full Text] [Related]
4. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646 [TBL] [Abstract][Full Text] [Related]
5. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells. Verhulst A; D'Haese PC; De Broe ME J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974 [TBL] [Abstract][Full Text] [Related]
6. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice. Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361 [TBL] [Abstract][Full Text] [Related]
7. HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model. Bababeygy SR; Polevaya NV; Youssef S; Sun A; Xiong A; Prugpichailers T; Veeravagu A; Hou LC; Steinman L; Tse V Anticancer Res; 2009 Dec; 29(12):4901-8. PubMed ID: 20044596 [TBL] [Abstract][Full Text] [Related]
8. Statin treatment and 3' polyadenylation of eNOS mRNA. Kosmidou I; Moore JP; Weber M; Searles CD Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773 [TBL] [Abstract][Full Text] [Related]
9. 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation. Guruvayoorappan C; Kuttan G J Exp Ther Oncol; 2008; 7(3):173-82. PubMed ID: 19066126 [TBL] [Abstract][Full Text] [Related]
10. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076 [TBL] [Abstract][Full Text] [Related]
11. Diverse effects of statins on angiogenesis: new therapeutic avenues. Elewa HF; El-Remessy AB; Somanath PR; Fagan SC Pharmacotherapy; 2010 Feb; 30(2):169-76. PubMed ID: 20099991 [TBL] [Abstract][Full Text] [Related]
12. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis. You JJ; Yang CH; Huang JS; Chen MS; Yang CM Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products. Liang YJ; Shyu KG; Wang BW; Lai LP Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884 [TBL] [Abstract][Full Text] [Related]
14. Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase. Izumi Y; Shiota M; Kusakabe H; Hikita Y; Nakao T; Nakamura Y; Muro T; Miura K; Yoshiyama M; Iwao H Hypertens Res; 2009 Aug; 32(8):675-9. PubMed ID: 19498441 [TBL] [Abstract][Full Text] [Related]
15. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells. Landsberger M; Jantzen F; Könemann S; Felix SB Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089 [TBL] [Abstract][Full Text] [Related]
16. Statins and the endothelium. Ii M; Losordo DW Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035 [TBL] [Abstract][Full Text] [Related]
17. The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation. Li H; Shi X; Liu J; Hu C; Zhang X; Liu H; Jin J; Opolon P; Vannier JP; Perricaudet M; Janin A; Soria C; Lu H Cancer Gene Ther; 2010 Oct; 17(10):700-7. PubMed ID: 20559333 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin attenuates monocyte-endothelial cell interactions and vascular free radical production in hypercholesterolemic mice. Li W; Asagami T; Matsushita H; Lee KH; Tsao PS J Pharmacol Exp Ther; 2005 May; 313(2):557-62. PubMed ID: 15665143 [TBL] [Abstract][Full Text] [Related]
19. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Diamant M; Tushuizen ME; Abid-Hussein MN; Hau CM; Böing AN; Sturk A; Nieuwland R Thromb Haemost; 2008 Sep; 100(3):489-97. PubMed ID: 18766267 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. Spiel AO; Mayr FB; Leitner JM; Firbas C; Sieghart W; Jilma B Thromb Res; 2008; 123(1):108-13. PubMed ID: 18433844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]